Alternatives to Respiro Diagnostics

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Revolutionizing genomic analysis with innovative sequencing technology.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Advancing next-generation mRNA medicines.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing an automated platform for liquid biopsy sample preparation.

AI-powered breast cancer detection and risk assessment solutions.

Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A vertically-integrated procurement platform for the life sciences industry.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

AI-powered precision testing for patient identification in clinics and clinical trials.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Develops nanostructured sensor chips for rapid pathogen identification in food.

Developing ultrasound-mediated nonviral genetic medicines.

Developing AI-powered diagnostics for neurodegenerative diseases.

Developing oral small molecule medicines for immunological and chronic diseases.

Developing advanced vision restoration technology through a retinal implant.

Developing novel therapies to reverse aging and extend lifespan.

Establishing the first comprehensive database of healthy pediatric tissue gene expression to understand genetic influences on childhood development and diseases.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Digital pathology imaging technology and AI-driven precision pathology software.

Developing lightweight bionic technology.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Developing a novel therapeutic approach for Alzheimer's disease.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing soft, stretchable brain-computer interface platforms.

Leveraging the adaptive immune system to diagnose and treat disease.

A biotechnology company focused on oncology drug discovery.

Developing novel male contraceptives.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.